Annex Advisory Services’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,371
Closed -$241K 383
2025
Q4
$241K Buy
+2,371
New +$190K ﹤0.01% 319
2023
Q3
Sell
-2,396
Closed -$225K 258
2023
Q2
$225K Buy
+2,396
New +$187K 0.01% 231
2022
Q2
Sell
-3,407
Closed -$238K 258
2022
Q1
$238K Sell
3,407
-36
-1% -$2.63K 0.02% 219
2021
Q4
$268K Buy
3,443
+1,294
+60% +$114K 0.02% 200
2021
Q3
$205K Sell
2,149
-740
-26% -$78.1K 0.02% 199
2021
Q2
$359K Hold
2,889
0.03% 166
2021
Q1
$381K Hold
2,889
0.04% 148
2020
Q4
$383K Buy
2,889
+200
+7% +$24.2K 0.04% 140
2020
Q3
$274K Sell
2,689
-58
-2% -$5.01K 0.03% 112
2020
Q2
$239K Buy
+2,747
New +$219K 0.03% 114
2018
Q4
Sell
-3,000
Closed -$237K 132
2018
Q3
$237K Buy
+3,000
New +$196K 0.04% 112

Other funds holding EXAS

Annex Advisory Services's EXAS Position: Q1 2026 in Review

Annex Advisory Services sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 2,371 shares — an estimated $241K sold.

Annex Advisory Services first reported a position in EXAS in Q3 2018 and held it in 11 quarters. The position peaked at $383K in Q4 2020. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Annex Advisory Services reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Annex Advisory Services sold 2,371 Exact Sciences shares in Q1 2026, an estimated $241K.
  • Annex Advisory Services first reported a position in Exact Sciences in Q3 2018 and held it in 11 quarters.
  • Annex Advisory Services's Exact Sciences position peaked at $383K in Q4 2020.
  • 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Annex Advisory Services's 13F filing for Q1 2026, filed 16 Apr 2026.